Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04017312 · ClinicalTrials.gov registry record · NA
A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting
A NA study, sponsored by Hill-Rom.
- Terminated
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT04017312 is a NA study that was terminated before completion, run by Hill-Rom. The registered enrollment target is 43 participants.
The verdict
NCT04017312, a NA study, was terminated before completion, sponsored by Hill-Rom.
- TERMINATED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This a 70 patient multi-site non blinded randomized control trial evaluating the use of the Vest® System for treatment of Non-Cystic Fibrosis Bronchiectasis (NCFBE) patients in the home setting. The study will assess outcomes in subjects requiring airway clearance therapy randomized to Oscillating Positive Expiratory Pressure (OPEP) therapy as the control group and High Frequency Chest Wall Oscillation (HFCWO) therapy as the intervention group
Interventions
- DEVICE High Frequency Chest Wall Oscillation
- DEVICE Oscillating Positive Expiratory Pressure (OPEP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2019-08-23 |
| Est. Completion | 2024-08-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04017312
The ClinicalTrials.gov registry entry for NCT04017312 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hill-Rom, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High Frequency Chest Wall Oscillation is the first listed.
NCT04017312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04017312 about?
NCT04017312 is a clinical study titled "A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting". This a 70 patient multi-site non blinded randomized control trial evaluating the use of the Vest® System for treatment of Non-Cystic Fibrosis Bronchiectasis (NCFBE) patients in the home setting. The study will assess outcomes in subjects requiring airway clearance therapy randomized to Oscillating P...
What is the current status of trial NCT04017312?
This trial is currently terminated. It is a NA study. The enrollment target is 43 participants. The study started on 2019-08-23. Estimated completion is 2024-08-06.
What interventions are being tested in trial NCT04017312?
The interventions under investigation include: High Frequency Chest Wall Oscillation (DEVICE), Oscillating Positive Expiratory Pressure (OPEP) (DEVICE).
Who is sponsoring clinical trial NCT04017312?
This trial is sponsored by Hill-Rom, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.